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Yeast probiotics and paraprobiotics, live and inactivated yeast cells, respectively,
improve health and performance of livestock by stabilizing the intestinal microbial
community. They have also been used for infection prevention and treatment. Despite
much research already conducted, the mechanism of direct antagonism, or adhesion of
bacteria to the probiotic/paraprobiotic, is under characterized. Additionally, it is unknown
which probiotic/paraprobiotic is optimal to use for specific infections. The interactions
between the yeast and certain pathogens were analyzed qualitatively with scanning
electron microscopy (SEM) and quantitatively with membrane filtration assays. Grampositive bacteria were found to exhibit specificity under SEM. Through membrane
filtration, Listeria monocytogenes exhibited binding to all samples (P<0.05), while
Salmonella Typhimurium exhibited binding (P<0.001) with all samples except with
2338. Escherichia coli O157:H7 only bound to the probiotics (P<0.001). With a better
understanding of how specific yeast probiotics and paraprobiotics interact with bacteria,
specific therapies can be administered to combat infections.
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CHAPTER I
LITERATURE REVIEW

Animal Health
Importance of animal health
Morbidity and mortality associated with livestock disease accounts for a large
economic burden worldwide. A major contributor to this economic burden is the cost
associated with illness. Livestock health not only impacts the livelihood of farmers, but
also veterinarians, food business owners who sell these animal products, and the food
consumers. Additionally affected are the health care systems, the tourism industries, and
the overall economy of the countries plagued with animal disease.
In 2001, a foot and mouth disease outbreak cost the United Kingdom an estimated
$12 billion (Anderson, 2002). In 1997, a swine fever epidemic in the Netherlands resulted
in the destruction of 11 million pigs and over $2 billion in loss (Horst et al., 1999). In
2007, an outbreak of avian influenza in Bangladesh cost the country’s poultry sector an
estimated $750 million (Samad, 2011). The monetary cost initially incurred due to the
direct loss of livestock is quite substantial, but another considerable cost that must be
taken into consideration is the economic impact on countries exterior to the disease. Once
a disease outbreak is recognized, a domino effect of preventative measures are taken,
such as the raising of border patrol awareness, development of contingency plans,
stockpiling of resources, and even restricting trade (reviewed in Pearson, 2005).
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One of the biggest influences on national, and sometimes international,
communities is the prevalence of human cases of zoonotic diseases (reviewed in Pearson,
2005). Zoonotic transfer has the potential to cause human outbreaks, such as is seen with
the avian influenza in 2003, Dengue fever in 2000, and rabies in 2005 (Koopmans et al.,
2004; Rahman et al., 2002; Schneider et al., 2009). It is estimated that nearly 61% of
known infectious organisms can be transferred zoonotically, and of that percentage, 31%
are bacteria (Taylor et al., 2001)
Foodborne pathogens
One of the main sources of foodborne illnesses is the consumption of food
products contaminated with bacteria. Products can become contaminated at multiple
points, starting with animal harvest processes and carrying through to improper handling
techniques by consumers during preparation and cooking. These illnesses account for
nearly 128,000 hospitalizations and 3,000 deaths each year in the United States alone
(Morris, 2011). Enteric bacterial pathogens display a wide array of virulence factors,
which enable them to affect and/or colonize their host. Some pathogens interact with the
intestinal tract or epithelium via adhesion or invasion, while others can secrete exotoxins
or cytotoxins (Guerrant et al., 1999). Of all the pathogens that affect both human and
animal health, the Centers for Disease Control and Prevention recognize the following
bacteria that account for the majority of these infections: Escherichia coli O157:H7,
Salmonella, Campylobacter, Listeria monocytogenes, Staphylococcus aureus, and
Clostridium perfringens. These organisms are not only the most common food-borne
pathogens, but they all have been linked to antibiotic resistance, which impacts treatment
options for not only humans, but livestock as well (Teuber, 1999).
2

Escherichia coli
The bacterium Escherichia coli is a Gram-negative, facultative anaerobe, human
commensal of the gastrointestinal tract and is one of the most commonly isolated
bacterial pathogens in the food industry (Matic et al., 1997). Hundreds of different
serotypes of E. coli exist, but few are considered pathogenic (Ray & Schaffer, 2011).
These pathogenic serotypes of E. coli are categorized by their specific pathogenic
mechanisms (e.g., toxins, adhesins, invasiveness, etc.), known as “virotypes” (Gonzalez
Garcia, 2002). These virotypes are enterotoxigenic E. coli (ETEC), enteroinvasive E. coli
(EIEC), enterohemorrhagic E. coli (EHEC), enteropathogenic E. coli (EPEC), and
enteroaggregative E. coli (EAEC) (Levine, 1987). Enterohemorrhagic strains of E. coli,
including the serotype O157:H7, are the causative agents of hemolytic uremic syndrome.
Escherichia coli O157:H7 causes this disease by adhering to the epithelium/endothelium,
inducing a lesion as well as releasing the Shiga toxin (Stx) that cleaves ribosomal RNA
and disrupts protein synthesis of the target cell, thereby leading to cell death (MeltonCelsa & O'Brien, 1998). Despite the severity of pathogenesis in humans, ruminants have
been known to be asymptomatic carriers of EHEC O157:H7 (Witold & Hovde, 2011).
Ruminants do not express the receptor for the Shiga toxins, thus the bacteria do not cause
disease in these animals (Pruimboom-Brees et al., 2000). The feces of ruminants are
considered the primary source of O157:H7 contamination of food supplies and
environments, but pigs, poultry, and dogs have been found to be sources as well (O'Brien
et al., 2001; Van Donkersgoed et al., 2001; Witold & Hovde, 2011).
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Salmonella
Salmonella are Gram-negative, non-spore-forming, nonencapsulated, motile
bacteria that cause many enteric diseases in both humans and animals. There are over
2,000 different serotypes of Salmonella. Salmonellosis, a diarrheal infection that can
result in fever and abdominal cramps is caused by various Salmonella subtypes such as S.
enterica Typhimurium, S. enterica Enteritidis, and S. enterica Heidelberg (Brenner et al.,
2000; Jones et al., 2008). Another serovar of importance to human and livestock health is
S. enterica Typhi, which is the causative agent of typhoid fever, a disease endemic across
the entire world (Rowe et al., 1997). These serovars are ubiquitous in nature and can
affect a wide array of livestock, such as cattle, chickens, swine, and turkeys (CDC, 2006).
Salmonella can colonize a multitude of sites within a host (e.g., small intestine, colon,
and cecum) through the utilization of fimbriae or pili for attachment and internalization
(Foley & Lynne, 2007).
The food industry has been widely affected by Salmonella. Salmonella Enteritidis
frequently contaminates poultry products and eggs, while S. Typhimurium has been
isolated from poultry and pork products (White et al., 2001). It has also been reported that
other food sources of Salmonella include milk and other dairy products, pork, vegetables,
and fruit (Helmick et al., 1994). A study conducted by the United States Department of
Agriculture (USDA) estimated that 85-96% of the 4 million total cases of non-typhoid
salmonellosis were foodborne, of which the total costs ranged between $0.6 and $3.5
billion annually, which marks salmonellosis as one of the most costly bacterial foodborne
diseases to date (Busby et al., 1996).
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Campylobacter
Campylobacter sp. are Gram-negative, microaerophilic, spiral-shaped bacteria
that are commonly associated with human gastroenteritis and peptic ulcers (Drumm et al.,
1987). The genus Campylobacter is comprised of 16 species, the most common being C.
jejuni, C. coli, C. lari, C. fetus, and C. upsaliensis (Fouts et al., 2005). The majority of
Campylobacter infections are from the intake of raw/undercooked foods, such as beef,
pork, poultry, lamb, and various seafood (Nielsen et al., 1997). The USDA estimates
around 1.3 – 1.7 million cases annually (7,000-9,000 hospitalizations and 100-500
deaths) are caused by foodborne Campylobacter, which results in an estimated cost of
$0.6 - $1.0 billion annually (Busby et al., 1996). It is even more prevalent in Europe,
where the European Union estimates around 9 million cases of campylobacteriosis occur
annually, resulting in a cost of $2.4 billion per year (Bahrndorff et al., 2013).
The main virulence factors of Campylobacter sp. are its motility, invasiveness,
catalase production, and its resistance to a number of antimicrobials (Bhavsar &
Kapadnis, 2006). Campylobacter infects the host by adhering and invading intestinal
epithelial cells (Fauchere et al., 1986). Once inside the epithelial cells, the bacteria will
release toxins that can damage tissue, resulting in inflammation, and thereby
gastroenteritis (Bhavsar & Kapadnis, 2006).
Listeria
The genus Listeria contains 7 different species, of which L. monocytogenes is the
primary species associated with regard to foodborne illnesses (Collins et al., 1991).
Listeria monocytogenes is a Gram-positive, facultative anaerobic, non-spore-forming
bacterium that is the causative agent of listeriosis (Glaser et al., 2001). Listeria colonizes
5

its host is through the utilization of internalin proteins InlA and InlB, which facilitate
internalization of the bacteria into target cells (Birmingham et al., 2007). Listeria utilizes
other proteins as well, including listeriolysin O (LLO) and phospholipase A (PlcA),
which promote its escape from phagocytic vacuoles, and actin assembly-inducing protein
(ActA) and phospholipase B (PlcB), which are integral for its intracellular actin-based
motility to promote cell-to-cell movement (Glaser et al., 2001).
There is a zero-tolerance policy for the presence of L. monocytogenes on readyto-eat food (Chen et al., 2003). The USDA estimates that approximately $0.3 billion are
lost annually due to illness and deaths caused by foodborne listeriosis (Busby et al.,
1996); this number increases to between $2.3 - $22 billion when including the cost of
industrial loss (Ivanek et al., 2005). Pregnancy-related listeriosis can lead to severe
neonatal disease or potentially fetal death (CDC 2011). Listeriosis can also cause bovine
abortions and stillbirths (Kirkbride, 1993). Although it is rare, cases of cutaneous
listeriosis have been reported in veterinarians and farmers exposed to contaminated
bovine products and also from amniotic fluid from livestock containing high
concentrations (108 CFU/mL) of Listeria (McLauchlin & Low, 1994).
Staphylococcus
As a normal inhabitant of the human microbiota, Staphylococcus sp. are Grampositive, non-motile, facultative anaerobic, coccus-shaped bacteria, and over 40 species
have been identified (Layer et al., 2006). Of those species, many are nonpathogenic, but
some do cause disease. Staphylococcus aureus is an opportunistic pathogen that has
gained much attention due to the increased prevalence of antibiotic resistant strains
(Lowy, 2000). Studies have shown that S. aureus can block components of the innate
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immune system by secreting various proteins, such as extracellular complement-binding
protein (Ecb) and extracellular fibrinogen-binding protein (Efb) (Jongerius et al., 2012).
The Ecb protein interferes with the activation of the C3 complement cascade by binding
to the C3d domain, while Efb also interferes with complement activation and also
prevents the adhesion of neutrophils to fibrinogen (Jongerius et al., 2012). Many clinical
strains of S. aureus express capsular polysaccharides that aid in evading the host immune
system (Harris et al., 2002). Staphylococcus aureus also produces five different toxins
that are capable of damaging cell membranes, four of which are hemolysins (i.e., α, β, γ,
and δ) and one is a leucocidin (Nilsson et al., 1999).
Staphylococcus aureus is associated with high mortality and morbidity in humans
who have hospital- or community-acquired infections, with severities ranging from nonlife-threatening skin disorders to bacteremia compounded with diseases such as
endocarditis and pneumonia (Klevens et al., 2007). Foodborne S. aureus infections result
in approximately $1 billion annually (Busby et al., 1996). Staphylococcus aureus has also
been found to infect a large array of animal species, such as household pets, horses,
cattle, pigs, and poultry (Weese, 2010).
Clostridium
Clostridium is a genus containing nearly 100 species of Gram-positive, obligate
anaerobic, spore-forming bacteria (Wells & Wilkins, 1995). The most common
pathogenic strains are C. botulinum, C. difficile, C. tetani, C. sordellii, and C.
perfringens. Clostridium sp. cause a variety of diseases (e.g., botulism and tetanus), but
in 2000 the poultry industry lost an estimated $2 billion worldwide due to necrotic
7

enteritis with C. perfringens being one of the etiological agents (McReynolds et al.,
2004).
Clostridium perfringens is characterized as expressing five different toxins (i.e.,
α, β, ε, ι, and θ), which are used to classify these bacteria into toxinotype A, B, C, D, or E
based on the specific toxin(s) expressed (Rumah et al., 2013; Wells & Wilkins, 1995).
Type A strains are commonly found as normal microflora within animals since they lack
some of the more potent toxins that are produced by the other types, but have been linked
to cases of necrotic enteritis in poultry, hemorrhagic diarrhea in dogs, and porcine
clostridial enteritis in neonatal and weaned pigs (Keyburn et al., 2006; J. G. Songer &
Uzal, 2005; Weese et al., 2001). Type B strains have been linked to dysentery,
hemorrhagic enteritis, and enterotoxemia in newborn lambs, neonatal calves and foals,
and sheep, respectively (Petit et al., 1999). Type C strains have been known to cause
enterotoxemia in sheep, but also necrotic enteritis in piglets, calves, foals, and lambs
(Petit et al., 1999). Type D strains have been linked to brain lesions in sheep and
enterocolitis and enterotoxemia in goats (Uzal & Kelly, 1998). Type E has been
diagnosed in calves and causes a severe local intestinal necrosis and systemic toxemia
analogous to type C (J.G. Songer & Miskimins, 2004).
Clostridium perfringens causes disease by coordination of direct toxins (e.g., beta,
alpha, and perfringolysin O) diffusing into the target cell (Sayeed et al., 2008). Alphatoxins are able to lyse cell membrane lecithins, which leads to cell membrane disruption
and eventually cell death, while theta toxins cause rapid tissue destruction (Wells &
Wilkins, 1995). Clostridial sp. produce the highest number of toxins of any bacteria;
therefore developing a disease prevention strategy is essential (Popoff & Bouvet, 2009).
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Antibiotics and probiotics
Antibiotics are compounds that exhibit bactericidal or bacteriostatic properties.
They have been used not only for the promotion of growth in food animals (Davies &
Davies, 2010), but also have been used to treat and prevent infections (McEwen &
Fedorka-Cray, 2002). However, resistance to these antibiotics became prevalent
whenever these antibiotics themselves came into existence (Phillips et al., 2003). For
instance before the introduction of penicillin as a therapeutic agent, bacterial
penicillinases (β-lactamases) were identified, so once the antibiotic was broadly utilized,
resistant strains of bacteria were selected for within the population (Davies & Davies,
2010). With this rising prevalence of antibiotic resistant bacteria, the shift away from the
use of antibiotics has led to the need of alternative methods of treatment or new
prevention strategies. Currently, probiotics are being used as preventative and therapeutic
treatments for diarrheal diseases and allergic diseases as well as supplemental
enhancements of vaccine-induce protective immunity (Vanderhoof & Young, 2004).
There are also some studies that suggest uses for probiotics in cancer prevention, immune
stimulation, allergy treatment and prevention, and respiratory disease reduction
(Vanderhoof, 2001). With all of these possible benefits, the use of probiotics presents a
favorable alternative to the use of antibiotics and may prove beneficial in reducing the
prevalence of antibiotic resistance.
Probiotics
Probiotics, although not seen as an immediate substitution for antibiotics, are
being considered as another possible answer to the emerging issue of antibiotic
resistance. Probiotics are defined by the World Health Organization and the Food and
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Agriculture Organization as “live organisms which when administered in adequate
amounts confer a health benefit on the host” (Reid et al., 2003). The gastrointestinal
microbiota is comprised of a gamut of microorganisms interacting with one another. This
microbiota is vital to host health, as it aids in food digestion and the “development and
optimal functioning of the immune system” (Hooper & Gordon, 2001). The microbiome
of the gut also represents an actual physical barrier that inhibits the growth and
colonization of pathogens, but once the gut microbiota is modified or altered, pathogens
can rapidly proliferate and cause a substantial shift in the normal microbial flora (Martin
et al., 2014). This shift in microbial community, also called dysbiosis, can be linked to
diseases such as irritable bowel syndrome, celiac disease, and even colorectal cancer
(Miquel et al., 2013). Probiotics confer a health benefit by stabilizing that microbial
balance (Fuller, 1992).
Bacterial probiotics versus yeast probiotics
Probiotics can be bacterial or yeast. The best-characterized bacterial probiotics
include various Lactobacillus species, Bifidobacterium species, Streptococcus species,
and other lactic/non-lactic acid bacterial species (Vemuri et al., 2013). Bacterial
probiotics are primarily used for preventing many illnesses and disorders, such as
acidosis. Acidosis is a digestive disorder that results from an accumulation of lactic acid
or volatile fatty acids (Nagaraja & Titgemeyer, 2007) and has been linked to a variety of
health issues including laminitis, bloat, and liver abscesses (Enemark, 2009; J.E. Nocek,
1997). Research has shown that lactic acid-producing bacteria have the ability to
maintain a steady level of lactic acid, which can reduce the risk of acidosis (Moran et al.,
2006; J. E. Nocek et al., 2002). An increase in growth performance has been seen when
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pigs were supplemented with lactic acid bacteria (Moran et al., 2006). However, the
survival rate of bacterial probiotics within the gastrointestinal tract is estimated to be
around 20-40% for most strains due to the acidity of the gut and bile salts encountered
(Bezkorovainy, 2001). It is believed that bacterial probiotics would be able to increase
their effect if they were to adhere to the mucosal cells, but it has been demonstrated that
some probiotics when administered exogenously do not adhere to the mucosal cells and
proceed directly into the feces (Bezkorovainy, 2001). Bifidobacterium has been reported
to endure the gastrointestinal stresses and still confer a health benefit despite its inability
to colonize (Fujiwara et al., 1997). It does so by producing a 100kDa protein which
interferes with pathogenic E. coli’s adhesion to intestinal epithelial cells. To be
administered as a prophylactic, bacterial probiotics must be ingested continually to ensure
competition with pathogens within the intestines.
Certain yeast can also be utilized as probiotics. The most commonly used are
Saccharomyces boulardii and S. cerevisiae. Research has demonstrated that S. cerevisiae
has the capability to colonize and replicate within the digestive tract (Martins et al.,
2005). Yeast probiotics are able to survive the low pH environment of the stomach (2.5 to
3.5) as well as the distal part of the gastrointestinal tract where local stresses, such as bile,
limit most microbial growth (Czerucka et al., 2007).
Administration of the yeast probiotic S. cerevisiae has been reported to reduce
mortality associated with infections with the pathogens Salmonella Typhimurium and
Clostridium difficile in a mouse model (Martins et al., 2005). Additionally, yeast
probiotics have been reported to help initiate microbial colonization within the rumen of
young ruminants if administered within the first few days after birth (Frederique
11

Chaucheyras-Durand & Fonty, 2002). Yeast probiotics have also been reported to induce
an increase in the digestion of fiber in the colon as well as regulate the microbial balance
of the hindgut (Jouany et al., 2008; Medina et al., 2002). For example, yeast probiotics
have been found to prevent the accumulation of lactate in horses, which can lead to
acidosis (Kronfeld & Harris, 1997; Potter et al., 1992). Normally, horse feed is
supplemented with large amounts of starch, but only a fraction is digested, which leaves
undigested starch to enter the hindgut. This disturbs the microbial balance, which leads to
accumulation of lactate. Yeast probiotics prevent this by initiating a healthy balance of
microorganisms, which prevents the buildup of lactate. Many probiotic bacteria have
been known to produce lactic acid (e.g., Lactobacillus sp., Bifidobacterium sp.), so yeast
probiotics present the best option against acidosis since yeasts do not naturally produce
lactic acid (Sauer et al., 2010).
Paraprobiotics
There has been an increased interest in cell wall components or non-viable
microorganisms as potential probiotics. The increased interest in these microbial
components is primarily due to the fact that providing live microorganisms has the
increased risk of morbidity and mortality with individuals with weakened immune
systems. These cell wall components, termed “paraprobiotics”, are defined as
components of microbial cells that confer a health benefit to the host. Paraprobiotics can
be made from both bacteria and yeasts. Bacterial paraprobiotics are comprised of cell
fractions of bacteria or inactivated cells (Taverniti & Guglielmetti, 2011). Yeast
paraprobiotics are also comprised of cell wall fractions or inactivated cells, and their
composition is comprised of β(1-3)-D-glucans, β(1-6)-D-glucans, chitin, and
12

mannoproteins, which elicit their protective effects by various mechanisms of action (F.
Chaucheyras-Durand et al., 2008; Kollar et al., 1997).
Yeast paraprobiotics have been used to increase milk production in dairy
ruminants, and various growth parameters in cattle, but these responses vary between
yeast strain depending on the diet and physiological status of the animal (F. ChaucheyrasDurand et al., 2008). Another study proved that supplementation with yeast
paraprobiotics resulted in positive weight gain and general productivity of lambs and
dairy cows (Jenkins & Jenkins, 2014). Paraprobiotics have been demonstrated to provide
similar results as probiotics in the induction of IL-8 and inhibition of pathogen binding to
the human colon epithelial cell line Caco-2 (Besselink et al., 2008; Lopez et al., 2008;
Ostad et al., 2009).
Mechanisms of action
Yeast probiotics and paraprobiotics confer benefits to the host by stabilizing the
normal gut microflora via a multitude of proposed mechanisms, including host immune
system modulation, active antimicrobial inhibition, and indirect mechanisms of actions
on pathogens, host, or food components. However, these mechanisms tend to vary
between strains (Hatoum et al., 2012; Ng et al., 2008; Oelschlaeger, 2010; Ohland &
MacNaughton, 2010).
There is much evidence of yeast probiotics and paraprobiotics interacting with the
host immune system in order to stimulate an immune response to combat pathogens.
Saccharomyces cerevisiae has been documented to significantly increase concentrations
of IgA and secretory components of immunoglobulins when orally administered to
growing rats (Buts et al., 1990). Administration of these yeast cell wall paraprobiotics
13

enhances the immunomodulatory response, but does so via a different mechanism than
that utilized by live microorganisms (reviewed in Auclair, 2001). Yeast cell wall
components have a role in activating the complement system due to the inner yeast cell
wall glucans (i.e., β-(1-3)-D-glucose) stimulating components of the mammalian immune
system, such as the inflammatory response and the reticuloendothelial system (Pillemer et
al., 1956). Glucans are believed to be immunostimulants since peripheral blood
leukocytes and extravascular macrophages have a specific glucan receptor, which, when
activated, can stimulate macrophages and the production of cytokines (Czop, 1986; Riggi
& Di Luzio, 1961; Song & di Luzio, 1979).
Yeast probiotics and paraprobiotics have been demonstrated to affect host internal
environments in order to disrupt pathogenic microbes’ enzymatic activities. In rumen
cannulated sheep that received live yeast supplements during diet changes, the rumen pH
was reported to sustain an environment optimal for rumen function, including higher
fibrolytic activities (Fonty & Chaucheyras-Durand, 2006). It has also been reported that
S. cerevisiae was able to outnumber Streptococcus bovis, a lactate-producing bacterium,
in vitro as well as limit the concentration of lactate produced by outcompeting for the
utilization of sugars (Chaucheyras et al., 1996). The reduction of lactate accumulation
and stabilization of rumen pH can lead to the decreased risk of pathogen colonization and
to the promotion of resident microbes (F. Chaucheyras-Durand & Durand, 2010).
Yeast probiotics have also been found to exhibit a protective effect for the host
against pathogenic bacteria. It is reported that S. boulardii demonstrated the capability to
reduce the amount of available toxins secreted by S. typhimurium and Shigella flexneri
and the capability to outcompete for adhesion sites within mice (Rodrigues et al., 1996).
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Some yeast have also been shown to produce antimicrobial peptides, called bacteriocins,
which hinder the growth of pathogens or hydrolyze their toxins (Woods & Bevan, 1968).
Direct antagonism
Yeast probiotics and paraprobiotics are well characterized in their abilities of
stabilizing pH in the gastrointestinal tract, inhibiting the growth of lactate-producing
bacteria, and modulating the host immune system. Though much has been done in terms
of defining the mechanism by which probiotics and paraprobiotics confer benefits, little
has been done to analyze the interaction, if any, that these products have with microbes
encountered within the host. One characteristic of yeast is their ability to directly interact
with bacteria. Certain serovars of S. enterica and E. coli have been found to bind to
mannose on the surface of yeast cell walls due to the bacterial expression of mannosespecific adhesins (Sharon & Ofek, 1986). Type I fimbrinated E. coli was found to bind to
mannose on yeast cell walls (Gedek, 1999; Sharon & Ofek, 1986). A study conducted at
the Universidade Federal de Minas Gerais demonstrated in vitro and in vivo the adhesion
of yeast probiotics, Saccharomyces boulardii and Saccharomyces cerevisiae, to
enteropathogenic bacteria (Tiago et al., 2012). With gnotobiotic mice that were exposed
to yeast probiotics prior to infection, Tiago demonstrated that the bacterial cells were
attracted to the surface of the yeast cells as opposed to the intestinal epithelials (Tiago et
al., 2012). This direct interaction between the probiotic/ paraprobiotic and pathogen (i.e.
direct antagonism) presents a mechanism of rapid pathogen elimination from a host
through defecation (Gedek, 1999; Normark et al., 1986). Although under-characterized,
direct antagonism presents an important mechanism of action for illness prevention.
15

Conclusion
Probiotics and paraprobiotics present a great alternative for disease prevention
and/or treatment, but their mechanisms of action are still under debate and are varied.
Bacterial probiotics confer many health benefits, but are limited due to their inability to
withstand certain stresses within the GI tract. Yeast probiotics and paraprobiotics are able
to endure the stresses encountered, therefore have the potential to confer a wide array of
health benefits to the host. This thesis focuses upon characterizing the mechanism of
direct antagonism as a method of pathogen removal from the host.
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CHAPTER II
CHARACTERIZATION OF THE ABILITY OF YEAST PROBIOTICS AND
PARAPROBIOTICS TO DIRECTLY INTERACT WITH GRAMPOSITIVE AND GRAM-NEGATIVE BACTERIA

Introduction
The use of antibiotics as a means for treating and preventing illness in livestock
has impacted animal health and performance (Dunlop et al., 1998). Antibiotics are
administered individually (e.g., cows, calves, sows) or supplemented in feed and water to
whole groups of animals (e.g., poultry, pigs) (McEwen, 2006). However, the increased
risk of antibiotics allowing for the proliferation of antibiotic resistant bacteria in a
microbial population has led to an increase in the use of probiotics. Probiotics, as defined
by The Food and Agriculture Organization of the United Nations (FAO) and the World
Health Organization (WHO), are “live organisms which when administered in adequate
amounts confer a health benefit on the host” (Nations, 2001). Since live microorganisms,
present a potential risk of infection to the host, especially if immunocompromised, the
FAO and WHO have constructed guidelines in order to properly identify and characterize
organisms as potential probiotics. Common probiotics recognized by the FAO and WHO
include Lactobacillus sp., Bacillus sp., Enterococcus sp., Saccharomyces sp., and
Aspergillus sp. (Frederique Chaucheyras-Durand & Fonty, 2002; Reid et al., 2003). Of
these, the yeast Saccharomyces boulardii and S. cerevisiae have been the most commonly
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used among livestock (Duarte et al., 2012; Martins et al., 2005). Yeast probiotics that
have been dried/fragmented into probiotic components have also been shown to confer a
health benefit to a host (Middelbos et al., 2007). These products are referred to as
“paraprobiotics” (Taverniti & Guglielmetti, 2011). Yeast cell walls are composed of β(13)-D-glucans, β(1-6)-D-glucans, chitin, and mannoproteins; interest has increased in yeast
paraprobiotics since research has demonstrated that inactivated bacterial paraprobiotics
can exert immunological effects on the host (Kollar et al., 1997; Taverniti &
Guglielmetti, 2011).
Yeast probiotics have multiple mechanisms of action by which they confer a
health benefit to the host, including direct binding to toxins produced by pathogens and
also stimulating the host immune system. Additionally, probiotics have the potential to
prevent colonization of bacteria to the mucosal surface of the intestine through either
direct antagonism or through competitive inhibition (Shoaf-Sweeney & Hutkins, 2008).
This inhibition is hypothesized to be due to the ability of certain pathogenic bacteria with
mannose-binding fimbriae to bind mannoproteins within yeast cell walls (Ofek et al.,
1977). By preventing the initial attachment to the intestinal epithelium and directly
adhering to the bacteria themselves, the yeast-bacteria complex that is formed will then
be removed via the digestive tract (Gedek, 1999). Despite previous research on the
binding effects of pathogenic bacteria to yeast, it is not known whether strain specificity
of adhesion within yeast products exists (Gedek, 1999; Korhonen et al., 1981; Martins et
al., 2010). Therefore, the objective of this study was to characterize the binding
relationship of multiple Saccharomyces cerevisiae probiotic and paraprobiotic products
with Gram-positive and Gram-negative bacteria.
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Materials and Methods
Bacterial and yeast strains and cultivation conditions
The bacterial strains used in this study were Escherichia coli O157:H7 (ATCC
43895), Salmonella enterica serovar Typhimurium (ATCC 13311), Salmonella enterica
serovar Enteritidis (ATCC 13076), Salmonella enterica serovar Heidelberg (ATCC
8326), Salmonella enterica serovar Typhi (ATCC 6539), Listeria monocytogenes
(F2365), and Clostridium perfringens (ATCC 13124). Escherichia coli O157:H7, L.
monocytogenes F2365, and all Salmonella strains were grown in tryptic soy agar or broth
(TSA/TSB) at 37°C. Clostridium perfringens was grown in clostridial reinforced medium
(CRM; BD 218081) anaerobically at 37°C. The Saccharomyces cerevisiae yeast samples
used in this study were the two live yeast probiotics (Batch 2775 and Procreatin 7) and
the three yeast cell wall paraprobiotics (Cell Wall Yeast #2194, Safmannan A #2338,
Safmannan #3711). All of the products were reconstituted in yeast peptone dextrose
(YPD) media at 37°C at a concentration of 0.1g/mL (~2x108 CFU/mL). The
concentrations of paraprobiotics were based on initial populations of the live yeast
probiotics and weighed out similarly. Viability of the products was verified by plating
aliquots on YPD agar. Where required, anaerobic conditions were achieved by using a
Coy anaerobic chamber with a gas mix of 5% H2 and 95% N2 (Type B, Coy Laboratory
Products INC.). Anaerotest strips and an oxygen sensor were used to monitor
anaerobiosis throughout the student.
Scanning Electron Microscopy Adhesion Assay
Overnight cultures of S. enterica Typhimurium, E. coli O157:H7, and L.
monocytogenes F2365 were cultured at 37°C with constant agitation in TSB. Overnight
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cultures of C. perfringens were grown at 37°C anaerobically in CRM. Overnight cultures
of the yeast probiotic samples Procreatin 7 and Batch 2775 and yeast paraprobiotic
samples 2194, 2338, and 3711 were cultured overnight at 37°C in YPD broth.
A Thermonox coverslip (Thermonox #174934) was placed in each well of a 6well culture plate. Overnight cultures of the yeast probiotics and paraprobiotics (2mL,
~4x108 CFU/ml) were added to coverslips and incubated at 37°C for ~16 h; coverslips
were then washed three times with 1X phosphate buffered saline (PBS). Overnight
bacterial cultures (5 mL) were pelleted for 5 min at 13,000 x g and resuspended in TSB at
a concentration of 2 x 1010 CFU/mL, at which point 1 mL of bacteria was added to the
yeast coverslips. The co-culture of yeast and bacteria was incubated for 4 h at 37°C, after
which each coverslip was washed with 1X PBS three times. After extensive washings, 23mL of 2.5% glutaraldehyde in PO4 fixative was added to each well. Each coverslip was
rinsed with distilled water, post-fixed with 2% osmium tetroxide (OsO4), rinsed again
with distilled water, and then dehydrated in a graded ethanol series (Merritt, 2009). Each
coverslip was critical point dried, mounted on aluminum stubs, and coated with 15nm
platinum. The coverslips were then viewed under a JEOL JSM-6500F scanning electron
microscope (SEM). Per coverslip, 40 yeast probiotic cells were counted, and of that
count, the number of yeast cells found with bacteria bound was used in calculating the
percent adherence per sample.
Membrane Filtration Adhesion Assay
Overnight bacterial and yeast cultures were prepared similarly as samples for
SEM analysis. Yeast were cultured for 16 h at 37°C in 50 mL conical tubes, after which
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50 uL (~1x106) was added to 4900µL of YPD, and co-cultured with 50 uL of bacteria
(~1x108 CFU/mL). The yeast+bacteria (YB) co-culture was vortexed and incubated for 4
h at 37°C. For controls, 50 µL of the bacterial culture was added to 4950 µL of YPD and
incubated for 4 h at 37°C. Following the 4 h incubation, 50µL of YB co-culture or
bacteria only control was added to 1450 µL of PBS in microcentrifuge tubes. Membrane
filters (3.0µm, Millipore SSWP09025) were first washed with 1500µL of PBS, then the
bacteria or YB mix was vacuum filtered, followed by a wash with 2000µL of PBS. The
resulting filtrate (5mL) was serially diluted in PBS and plated onto TSA. Viable bacterial
colonies were counted on the plates following a 24 h incubation at 37°C. A minimum of
three independent replicates was conducted.
Yeast Probiotic and Paraprobiotic Supernatant Effect Assay
Bacterial and yeast cultures were prepared similarly to the membrane filtration
assay. Yeast (concentration needed) were cultivated for 16 h at 37°C and vacuum filtered
using 3.0µm membrane filters. Fifty uL of the resulting filtrate was added to 4900uL of
YPD and co-cultured with 50 uL of bacteria (1x108 CFU/mL). The supernatant+bacteria
(SB) co-culture was then vortexed and incubated for 4 h at 37°C. For controls, 50 µL of
the bacterial culture was added to 4950 µL of YPD and incubated for 4 h at 37°C.
Following the 4 h incubation, 50µL of the SB co-culture was serially diluted in PBS and
plated onto TSA. Viable bacterial colonies were counted on the plates following a 24 h
incubation at 37°C. A minimum of three independent replicates was conducted.
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Yeast Lysate Growth Analysis
All yeast probiotics and paraprobiotics were reconstituted at 0.2g into 5mL
mineral salts medium (MSM) with no glucose, and vortexed. The medium per 1000 mL
contained 9.0g Na2HPHO4, 1.5g KH2PO4, 1.0g NH4Cl, 0.2g MgSO47∙H20, 0.02g
CaCl2∙2H20, 1.2mg FeNH4-citrate, and 2mL Hoagland’s Solution, pH 6.9 (Schlegal,
Kaltwasser, and Gottschalk, 1961. Arch Microbiology 38:209-222). Yeast products were
lysed on ice using a sonicator (Fisherbrand Sonic Dismembrator Model 100, setting 3) for
eight 1-min intervals, with 1 min cooling on ice between intervals. Yeast lysates were
collected after centrifugation for 2 min at 12,000 x g and filtered using a syringe filter
(Milliplex 0.2μm filter). Overnight (2 mL) cultures of all Salmonella strains (i.e.,
Typhimurium, Typhi, Enteritidis, and Heidelberg) were centrifuged at 13,000 x g for 2
min, washed twice with 1 mL MSM (no glucose), then resuspended in 2 mL of MSM (no
glucose). For analysis of Listeria monocytogenes, overnight cultures were centrifuged,
washed twice with 1 mL of glucose limited mineral media (GLMM) and resuspended in 2
mL of GLMM without glucose (Schneebeli & Egli, 2013). The yeast lysates were added
to a 96-well plate in 20 µL increments to 2 µL of bacterial cells and 180 µL of MSM (no
glucose); as a control, bacteria were added to MSM supplemented with 3% glucose.
Growth of the bacteria was monitored using a PowerWave plate reader (BioTek), with
OD600 collected every 1 h for 16 h. Growth was analyzed in a minimum of three
replicates.
Statistical Analysis
The data from the SEM adhesion assay and the membrane filtration adhere assay
were analyzed using the GLIMMIX Procedure using SAS (SAS Inst. Inc.; Cary, NC).
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Significance was declared at P < 0.05. Within both assays, the four bacterial strains were
co-incubated with five different yeast samples, the amount of adhesion was counted
(n=50) per coverslip, and those data were tested for contrasts. When overall significant
differences (P < 0.05) existed among the samples, Tukey Grouping for Least Squares
Means option of SAS was used to separate the sample (SAS Inst. Inc.; Cary, NC). The
membrane filtration adhesion assay included one sample per bacterium that did not
contain any yeast sample (bacterial control).
Results
Direct binding of bacteria to yeast probiotics and paraprobiotics varies.
The SEM adhesion assay was used to qualitatively determine whether the yeast
probiotics and paraprobiotics bound to E. coli O157:H7, L. monocytogenes, S.
Typhimurium, and C. perfringens (Fig. 2.1). C. perfringens exhibited binding to the
paraprobiotic Safmannan 3711 as compared its interaction to the other yeast products (P
< 0.001; Fig. 2.2). O157:H7 bound exhibited the least amount of binding to Safmannan A
2338, but bound to all other yeast products with similar affinity. S. Typhimurium
exhibited no preference to any of the yeast products with an average adherence of 92%.
F2365 also exhibited no preference to any of the yeast products, but unlike S.
Typhimurium, F2365, as well as O157:H7, displayed low percentages of binding, with
averages of 6.43% and 10.59%, respectively.
Averaging the mean adhered of each Gram reactivity group from the SEM assay,
the Gram-positive bacteria (L. monocytogenes and C. perfringens) were found to exhibit
preferential binding with the probiotic Procreatin 7 and the paraprobiotics Safmannan A
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2338 and Safmannan 3711 (Fig. 2.3). The Gram-negative bacteria (E. coli and
Salmonella) demonstrated no preference to any yeast product (P > 0.05).
The membrane filtration adhesion assay was used to accurately quantify the
binding efficiency of each yeast probiotic and paraprobiotic to each bacterium. The
results of the membrane filtration adhesion assay varied from strain to strain of bacteria
(Fig. 2.4). Escherichia coli O157:H7 bound (P < 0.001) to both probiotics, but did not
exhibit binding to any of the paraprobiotics. Listeria monocytogenes F2365 bound with
all yeast samples (P < 0.05). Salmonella Typhimurium bound well to all yeast samples (P
< 0.001), except for the paraprobiotic Safmannan A 2338. While the ability of Salmonella
Typhimurium to bind to yeast paraprobiotic 2338 was not different than the control, there
was a significant difference of this binding efficiency when compared to all of the other
yeast binding efficiencies (P < 0.001).
In order to confirm that the decrease in bacterial concentration in the membrane
filtration adhesion assay was due to bacterial binding to the yeast samples and not due to
extracellular components of the yeast impeding the viability of the bacteria, the
supernatants of the yeast products were co-incubated with the bacteria. None of the
supernatants exhibited a significant effect on bacterial growth (Fig. 2.5).
Growth of bacteria in MSM/GLMM containing yeast probiotic/paraprobiotic lysate
From the filtrate analysis, the paraprobiotic 2338 appeared to improve the growth
of S. enterica Typhimurium. To determine whether this indicated that Salmonella was
utilizing components of the product as a carbon source, the cytoplasmic components of
the yeast products were collected and added to minimal media lacking carbon. Four
serovars of Salmonella were analyzed. Salmonella Heidelberg and S. Enteritidis exhibited
34

the most growth with both yeast probiotic lysates (P < 0.05), S. Typhimurium exhibited
growth with the Procreatin 7 lysate (P < 0.05), but S. Typhi exhibited no significant
growth with either probiotic lysates (Fig. 2.6). All Salmonella strains exhibited a similar
increase in growth with the yeast paraprobiotic lysates 2194 and 3711, but only S.
Heidelberg and S. Enteritidis exhibited significant growth in Safmannan 2338 (Fig. 2.7).
To determine whether the impact on growth was limited to Salmonella, L.
monocytogenes F2365 was also analyzed (Fig. 2.8). Yeast probiotic 2775 and
paraprobiotic 2194 were selected due to their efficiency in binding in the membrane
filtration adhesion assay. Listeria monocytogenes F2365 exhibited an increase in growth
with the probiotic 2775 lysate (P < 0.05), but was not able to sustain growth in the
presence of the paraprobiotic 2194 lysates after 8 h.
Discussion
In order to characterize the relationship between pathogenic bacteria and
probiotics/paraprobiotics, we qualitatively and quantitatively analyzed the binding of E.
coli O157:H7, S. Typhimurium, L. monocytogenes, and C. perfringens to either live yeast
probiotics or yeast cell wall paraprobiotics. Previous probiotic studies have suggested a
correlation between the administration of probiotics and the decrease in concentrations of
E. coli O157:H7 in adult ruminants and in vitro in sheep fecal suspensions (F.
Chaucheyras-Durand et al., 2006; Stephens et al., 2007; Tabe et al., 2008). This could be
attributed to the probiotics’/paraprobiotics’ ability to bind directly to bacteria, allowing
for the yeast-bacteria cluster to be removed from the host (Gedek, 1999). Research into
this mechanism of action has confirmed such binding interactions in vitro, but has
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revealed specificity with binding potentials between various bacterial strains and yeast
samples.
Using SEM, the interaction between yeast probiotics and bacteria was further
analyzed. The Gram-positive bacterial strains exhibited significant binding to three of the
five yeast products (one probiotic and two paraprobiotics). The Gram-negative bacterial
strains displayed no preference in binding, indicating that the Gram-negative bacteria
bound to all yeast samples similarly. This was to be expected as Salmonella
Typhimurium and Escherichia coli have both been found to express mannose-specific
adhesins that allow for direct interaction with yeast cell walls (Sharon & Ofek, 1986).
As the SEM was only used to qualitatively assess the binding interaction between
yeast and bacteria, the membrane filtration adhesion assay was used to quantitatively
assess the binding potentials of each bacterial strain to each yeast product. During
processing in the SEM assay, the majority of yeast and bacteria that were unadhered to
the coverslip were washed away, so the actual binding efficiencies could differ from what
is displayed on the coverslip. The Gram-negative bacteria previously thought to exhibit
no preference to any of the yeast samples as displayed in the SEM assay, bound well (P <
0.05) to both yeast probiotics and varied between the yeast paraprobiotics in the
membrane filtration assay. Salmonella Typhimurium bound well to all paraprobiotics
except for Safmannan A 2338 (P < 0.01). Although it was not different when compared
to the control, the binding potential of S. typhimurium with paraprobiotic 2338 is
significantly different when compared to the binding potentials of S. typhimurium with
the other yeast samples. Since all of the yeast samples were of different strains of S.
cerevisiae, this particular binding potential suggests strain specificity of S. Typhimurium
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to the yeast samples. This was unexpected as S. Typhimurium bound well to all yeast
samples (>86%; Fig. 2.2). This suggests that the components of the yeast paraprobiotic
2338 could have served as a source of nutrients, positively affecting the growth of S.
typhimurium.
The live yeast probiotics exhibited the greatest amount of binding to all bacteria
when compared to the control. On average, all of the yeast samples significantly bound to
all of the bacteria as compared to the bacterial control. This result was expected since
probiotics have all of their yeast cell wall components and surface-anchored proteins still
intact and available for the bacteria to bind. The yeast paraprobiotics were dehydrated or
fractionated during their individual processing procedures, and those cell wall
components and surface proteins used for binding could have been damaged or
denatured.
In order to pursue the impact that Safmannan A 2338 had on the viability of S.
Typhimurium, four different strains of Salmonella were cultivated in MSM media
supplemented with the lysate of the yeast samples. When cultivated in MSM media
supplemented probiotic lysate after 6 – 8 h, S. Heidelberg and S. Enteritidis exhibited an
increase in growth with both probiotics (P < 0.05), while S. Typhimurium only exhibited
growth with the Procreatin 7 lysates (P < 0.05) and S. Typhi exhibiting no significant
growth with either probiotic lysate. The yeast paraprobiotics were also subjected to the
same lysis procedure even though some may have already been fractionated due to
processing. When cultivated in the MSM+paraprobiotic lysates after 6 – 8 h, all
Salmonella strains displayed a similar increase in growth with most of the yeast
paraprobiotics. This may be a result of the paraprobiotics already being fractionated,
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allowing for easier access to the cellular components needed for nutrients. When Listeria
monocytogenes was also used in this assay, the yeast probiotic 2775 yielded an increase
in growth while the yeast paraprobiotic 2194 could not sustain growth after 8 h. These
results support the hypothesis that the cellular components of these yeasts improve the
viability of certain bacteria by providing a source of nutrients, but the amount of growth
is bacterial strain dependent as well as yeast strain dependent. Further research is needed
to determine how various strains of yeast affect the growth of bacteria.
Conclusion
Pathogenic bacteria affect both humans and animals through a wide array of
virulence factors. Yeast probiotics and paraprobiotics are being explored as not only a
prophylactic use, but also therapeutic use in animal and human health. Though it is
known that these products confer a health benefit to the host, limited information is
known in regards to the mechanism of action by which these products impart this benefit.
This study explored the relationship of direct antagonism between the probiotics and a
variety of pathogens using an in vitro approach. Although adhesion was observed with all
bacterial strains, the binding potentials were strain-specific and yeast sample typespecific. Further research is warranted to conclude how various yeast probiotics and
paraprobiotics directly interact with pathogenic bacteria. Additionally, future in vivo
studies are needed to determine how these findings relate to overall impacts in animal
health.
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Figure 2.1

SEM images of pathogenic bacteria adhered to yeast probiotics and
paraprobiotics via direct antagonism.

(A) E. coli O157:H7 bound to yeast paraprobiotic 3711. (B) S. enterica serovar
Typhimurium bound to yeast paraprobiotic 3711. (C) L. monocytogenes F2365 bound to
yeast paraprobiotic 2194. (D) C. perfringens bound to yeast probiotic Procreatin 7.
Samples (A) – (C) were prepared aerobically, and Sample (D) was prepared
anaerobically. Yeast probiotics/paraprobiotics were co-incubated with bacteria for 4
hours on Thermonox coverslips and imaged by scanning electron microscopy.
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Figure 2.2

Percent adherence of E. coli O157:H7, S. Typhimurium, and L
monocytogenes to yeast probiotics and paraprobiotics.

Probiotics 2775 and Pro7 and paraprobiotics 2194, 2338, and 3711 were co-incubated
with bacteria in 6-well dishes on Thermonox coverslips and then washed extensively to
remove any unadherent bacteria. Coverslips were analyzed using scanning electron
microscopy (JEOL 6500F). A sample size, n=50, was used for each sample when
counting the amount of yeast binding events (adherence versus non-adherence). Shown
are the percent adherences per yeast sample to each bacterium plus and minus standard
error. Data analysis was done using SAS using the GLIMMIX Procedure.

40

Figure 2.3

Adhesion of Gram-negative and Gram-positive bacteria to yeast probiotics
and paraprobiotics.

Probiotics 2775 and Pro7 and paraprobiotics 2194, 2338, and 3711 were co-incubated
with bacteria in 6-well dishes on Thermonox coverslip and then washed extensively to
remove any unadherent bacteria. Coverslips were analyzed using scanning electron
microscopy (JEOL 6500F). A sample size, n=50, was used for each sample when
counting the amount of yeast binding events (adherence versus non-adherence). Shown is
the mean adherence per yeast sample plus and minus standard error. The letters represent
the level of significance between each of the samples with each letter significantly
different than the other. Multiple samples share a letter due to not being significantly
different. Data analysis was done using SAS using the GLIMMIX Procedure.
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Figure 2.4

Adhesion of Escherichia coli O157:H7, S. Typhimurium, and L.
monocytogenes with each yeast probiotic/paraprobiotic.

During the membrane filtration adhesion assay, probiotics 2775 and Pro7 and
paraprobiotics 2194, 2338, and 3711 were co-incubated with bacteria and filtered using a
3 µm membrane filter. Binding efficiencies monitored by viable plate counts from filtrate
of each yeast sample. Values represent the average log10 CFU/mL values plus and minus
standard error. Statistical analysis was performed using SAS using the GLIMMIX
Procedure.
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Figure 2.5

Percent survival of Escherichia coli O157:H7, S. Typhimurium, and L.
monocytogenes co-incubated with the supernatant of yeast probiotics and
paraprobiotics.

During the membrane filtration adhesion assay, the supernatants of probiotics 2775 and
Pro7 and paraprobiotics 2194, 2338, and 3711 were collected and co-incubated with
bacteria and filtered using a 3 µm membrane filter. Growth monitored by viable plate
counts with filtrate of each yeast sample. Values represent the average log10 CFU/mL
values plus and minus standard error of each co-incubation set of samples (O157:H7,
F2365, S. typhimurium) compared to bacterial control sets of each bacterium. There were
no significant differences between any co-incubation sets and their corresponding
bacterial control set. Data analysis was done using SAS using the GLIMMIX Procedure.
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Figure 2.6

Growth of various strains of Salmonella (typhi, typhimurium, Heidelberg,
enteritidis) grown with lysates of yeast probiotics in MSM

Each Salmonella strain (typhi, typhimurium, Heidelberg, enteritidis) was cultured in
mineral salts media media (MSM) supplemented with the lysate of each yeast probiotic
(2775 and Procreatin 7). A control of each Salmonella strain was cultured in MSM (Glucose). Growth was monitored hourly at 37°C for 16 h by plate reader. Values
represent average OD600 values plus and minus standard error.
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Figure 2.7

Growth of various strains of Salmonella (typhi, typhimurium, Heidelberg,
enteritidis) grown with lysates of yeast paraprobiotics in MSM.

Each Salmonella strain (typhi, typhimurium, Heidelberg, enteritidis) was cultured in
mineral salts media media (MSM) media supplemented with the lysate of each yeast
paraprobiotic (3711, 2194, and 2338). A control of each Salmonella strain was cultured in
MSM media (-Glucose). Growth was monitored hourly at 37°C for 16 h by plate reader.
Values represent average OD600 values plus and minus standard error.
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Figure 2.8

Growth of Listeria monocytogenes F2365 grown with the lysates of a yeast
probiotic and paraprobiotic in GLMM.

Listeria monocytogenes F2365 was cultured in three different glucose limited mineral
media (GLMM): GLMM (no glucose), GLMM (with lysate of yeast paraprobiotic 2194),
and GLMM (with lysate of yeast probiotic 2775). Growth monitored by plate reader.
Growth monitored by plate reader at 37°C for 24 h, OD600 reading taken every 1 h.
Values represent average OD600 values plus and minus standard error.
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CHAPTER III
CONCLUSION

Yeast probiotics and paraprobiotics represent important alternatives to the use of
antibiotics for treatment of bacterial infections. Yeast probiotics and paraprobiotics
exhibit a wide array of mechanisms of action, ranging from host immune stimulation to
host microbial community stabilization to toxin/bacterial cell adhesion (F. ChaucheyrasDurand et al., 2008).
The binding effect of yeast probiotic and paraprobiotics on several different
Gram-positive and Gram-negative pathogenic bacteria was investigated through a
literature review in Chapter 1 of this thesis. The aim of this review was to explain how
yeast probiotics and paraprobiotics interact with bacteria and interfere with bacterial
pathogenesis. The review also discusses information regarding the direct adherence of
probiotics to bacteria that allow for the removal of pathogens (Gedek, 1999).
Unfortunately, variations in the adhesion capabilities between bacteria have complicated
research deciphering this mechanism of action (Rajkowska, 2012). Variations in the
binding potential demonstrated by Rajkowska and colleagues led to the hypothesis that
yeast probiotics and paraprobiotics exhibit specific binding patterns against bacteria.
To further investigate the strain specific interactions of yeast probiotics and
paraprobiotics to various pathogenic bacteria, Escherichia coli O157:H7, Listeria
monocytogenes, Salmonella Typhimurium, and Clostridium perfringens were co49

incubated with five different strains of Saccharomyces cerevisiae-based samples (two
probiotics and three paraprobiotics) on Thermonox coverslips under aerobic or anaerobic
conditions, depending on the specific bacterial growth requirements. The coverslips were
processed for scanning electron microscopy, and the amount of yeast cells with bacteria
bound were assessed for percent adherence. While the Gram-positive bacteria overall
displayed strain-specific binding, the Gram-negative bacteria overall displayed no
significant difference in binding to any of the yeasts.
To quantitate the efficiencies, each co-incubation mixture was filtered to
accurately quantitate the binding of each bacterial species to each yeast sample. When the
log10 concentrations of each filtrate were compared to their bacterial control, L.
monocytogenes F2365 exhibited significant binding to all yeast samples, E. coli O157:H7
exhibited significant binding to only the yeast probiotics, and S. typhimurium exhibited
significant binding to all yeast samples except yeast paraprobiotic 2338. This strain
specificity led to another question of whether or not the bacteria may be using these
paraprobiotics as nutrients. To investigate that question, all yeast samples were lysed and
supplemented into minimal media lacking a carbon course. Four strains of Salmonella
and L. monocytogenes strain F2365 were grown in the minimal media supplemented with
yeast lysate. Two strains of Salmonella and F2365 exhibited growth with the probiotics.
All four strains of Salmonella exhibited growth with all yeast paraprobiotics, while
Listeria monocytogenes was able to grow in both probiotic 2775 and paraprobiotic 2194.
This result further validated the existence of strain specificity being displayed when
bacteria interact with these yeast samples.
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Despite these results, there are limitations to this study. Saccharomyces cerevisiae
is the only type of probiotic/paraprobiotic used in this project. Expanding this sample size
to include other strains of Saccharomyces as well as include some bacterial
probiotics/paraprobiotics would further validate not only the mechanism of direct
antagonism with probiotics and paraprobiotics, but also provide a comparison experiment
of bacteria to yeast when referring to probiotic mechanisms of action. Expanding the
library of pathogenic bacteria would also help to verify the strain specificity.
The importance of this work rests in its ability to provide insight to the interaction
of yeast probiotics and paraprobiotics to various pathogenic bacteria. With this
knowledge, the idea of treating infections specifically with a particular probiotic is a
possibility. Further research is warranted to confirm if this mechanism of direct
antagonism can be used as a valid mechanism for probiotic action.
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APPENDIX A
COMPLETE SEM ADHESION ASSAY RESULTS: ALL BACTERIA
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Scanning Electron Microscopy Adhesion Assay
Bacterial strains and cultivation methods
The bacterial strains used in this study were Escherichia coli O157:H7 (ATCC
43895), Salmonella enterica serovar Typhimurium (ATCC 13311), Listeria
monocytogenes (F2365), and Clostridium perfringens (ATCC 13124), Clostridium
difficile (ATCC NR-32882), Porphyromonas assacharolyticus (ATCC 25260),
Bacteroides fragilis (ATCC 25285), Arcanobacterium pyogenes (ATCC 19411),
Fusobacterium necrophorum (ATCC 25286), Salmonella enterica serovar Enteritidis
(ATCC 13076), Salmonella enterica serovar Heidelberg (ATCC 8326), Salmonella
enterica serovar Typhi (ATCC 6539), and Salmonella enterica serovar Dublin (ATCC
NR-28793). Escherichia coli O157:H7, L. monocytogenes F2365, and all Salmonella
strains were grown in tryptic soy agar or broth (TSA/TSB) at 37°C. C. perfringens and C.
difficile was grown in clostridial reinforced medium (CRM; BD 218081) anaerobically at
37°C. B. fragilis and P. assacharolyticus was grown on Brucella broth with Vitamin K
and hemin (BRU-BROTH; Anaerobe Systems AS-105) anaerobically at 37°C. F.
necrophorum and A. pyogenes were grown in Chopped meat glucose broth (CMG;
Anaerobe Systems AS-813) anaerobically at 37°C. The Saccharomyces cerevisiae yeast
samples used in this study were the two live yeast probiotics (Batch 2775 and Procreatin
7), and the three yeast cell wall paraprobiotics (Cell Wall Yeast #2194, Safmannan A
#2338, Safmannan #3711). All of the products were reconstituted in yeast peptone
dextrose (YPD) media at 37°C at a concentration of 0.1g/mL (~2x108 CFU/mL).
Viability of the live products was verified on YPD agar.

54

Materials and Methods
Overnight cultures of all bacteria were cultured at 37°C with constant agitation
either aerobically or anaerobically in their respective media depending on their growth
requirements. Overnight cultures of the yeast probiotic samples Procreatin 7 and Batch
2775 were cultured at 37°C in Yeast Peptone Dextrose broth (YPD). Overnight cultures
of the yeast paraprobiotic samples 2194, 2338, and 3711 were cultured at 37°C in YPD
broth.
A Thermonox coverslip (Thermonox #174934) was placed in each well of a 6well culture plate. Overnight cultures of the yeast probiotics and paraprobiotics (2mL,
~4x108 CFU/ml) were added to coverslip and incubated at 37°C for ~16 h. Overnight
bacterial cultures (5 mL) were pelleted for 5 min at 13,000 x g and resuspended in 6 mL
of TSB. Bacteria (1 mL) were added to the yeast at a concentration of 2 x 1010 CFU/mL,
as determined by the optical density (OD600) of 0.2 (Nanodrop ND-1000). The co-culture
of yeast and bacteria was incubated for 4 h at 37°C, after which each coverslip was
washed with 2-3mL of 1X phosphate buffered saline (PBS) three times. After extensive
washings, 2-3mL of 2.5% glutaraldehyde in PO4 fixative was added to each well. Each
coverslip was rinsed with distilled water, post-fixed with 2% osmium tetroxide (OsO4),
rinsed again with distilled water, and then dehydrated in a graded ethanol series (Merritt,
2009). Each coverslip was critical point dried, mounted on aluminum stubs, and coated
with 15nm platinum. The coverslips were then viewed under a JEOL JSM-6500F
scanning electron microscope (SEM) at 5 kb. Per coverslip, 50 yeast probiotic cells were
counted, and of that count, the number of yeast cells found with bacteria bound was used
in calculating the percent adherence per sample.
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Results and Discussion
The data collected from the complete SEM adhesion assay could not be used.
Limiting the initial scope of the assay to only two Gram-positive and two Gram-negative
bacteria allowed for the same bacteria to be used throughout all assays. The anaerobic
bacteria were difficult to use in the Membrane filtration adhesion assay due to the actual
filtration protocol. No growth was exhibited after the filtration and dilution steps with any
of the anaerobic bacteria.
The percent adherence of each bacterium to each yeast probiotic and
paraprobiotic is displayed in Table A.1, and the statistical analysis of the binding
potentials of each bacterium between each yeast sample is displayed in Table A.2.
Table A.1

Percent adherence of pathogenic bacteria to yeast probiotics and
paraprobiotics

Bacteria

2775
% Adhere

Pro7
% Adhere

2194
% Adhere

2338
% Adhere

3711
% Adhere

S. typhimurium
E. coli O157:H7
L. monocytogenes
C. perfringens
C. difficile
P. assacharolytica
B. fragilis
A. pyogenes
F. necrophorum
S. enteritidis
S. Heidelberg
S. typhi
S. Dublin

92.31%
10.76%
8.69%
35.61%
17.24%
85.63%
55.32%
39.05%
13.51%
49.09%
29.30%
65.08%
34.00%

96.67%
9.93%
6.25%
37.32%
20.97%
31.79%
13.51%
17.11%
55.32%
55.22%
30.43%
58.83%
9.09%

88.89%
15.04%
1.96%
41.23%
0.00%
0.00%
37.50%
0.00%
37.50%
16.67%
24.99%
21.53%
12.00%

85.71%
1.49%
9.37%
30.09%
5.00%
0.00%
15.22%
0.00%
15.22%
0.00%
46.43%
59.32%
0.00%

98.11%
12.04%
5.88%
75.00%
0.00%
0.00%
4.55%
0.00%
4.55%
11.90%
22.22%
50.00%
6.00%
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S. typhimurium
E. coli O157:H7
L. monocytogenes
C. perfringens
C. difficile
P. assacharolytica
B. fragilis
A. pyogenes
F. necrophorum
S. enteritidis
S. Heidelberg
S. typhi
S. Dublin
<.0001
<.0001

0.7937
0.5975
0.8604
0.0065
<.0001
0.2219
<.0001
0.0095
<.0001
0.9892
<.0001
0.0040

0.9981
0.9649
0.9952
0.9458
<.0001
<.0001
<.0001
<.0001
0.9188
0.9999
0.9495
0.0005

<.0001

0.9666

0.3447
<.0001

0.4914

0.9296

<.0001

0.1756

<.0001

<.0001

0.9970

<.0001

<.0001

0.0109

<.0001

0.9647

0.9970

0.6970

2775 vs
3711
P-value

<.0001

0.1114

0.8584

0.9999

0.0435

0.8199

0.9723

0.8579

2775 vs
2338
P-value

2775 vs
2194
P-value

2775 vs
Pro7
P-value

1.0000
0.5597

0.9890

0.3715

<.0001

<.0001

0.0388

0.9970

<.0001

0.0125

0.6568

0.9437

0.0576

0.0003

0.9720

<.0001

0.2219

0.0361

0.0095

<.0001

0.0003

0.9516

0.8016

0.6073

0.3014

P-value

P-value
0.5217

Pro7 vs
2338

Pro7 vs
2194

0.9861

0.8757

0.8760

<.0001

<.0001

0.0417

0.1756

<.0001

0.0007

<.0001

1.0000

0.9744

0.9899

P-value

Pro7 vs
3711

1.0000

0.2980

0.0005

0.2002

0.1908

0.8680

0.0163

0.9981

0.9735

<.0001

1.0000
0.0330

<.0001

1.0000

1.0000
0.0330

1.0000

<.0001

0.8542

0.9668

0.4214

2194 vs
3711
P-value

0.8555

0.4093

0.5674

0.0111

0.9853

2194 vs
2338
P-value

0.8680

0.8664

0.1036

0.6420

0.1057

1.0000

0.1057

1.0000

0.8757

<.0001

0.9452

0.0361

0.2684

2338 vs
3711
P-value

Statistical analysis of binding potentials of pathogenic bacteria to yeast probiotics and paraprobiotics

Bacteria

Table A.2

